Skip to main content

and
  1. No Access

    Article

    Dose proportionality of nadolol pharmacokinetics after intravenous administration to healthy subjects

    To support the increasing use of intravenous β-blockers during cardiovascular emergency and surgery, dose proportionality of pharmacokinetics of nadolol was evaluated after intravenous administration of 14C-nadol...

    R. A. Morrison, S. M. Singhvi, W. A. Creasey in European Journal of Clinical Pharmacology (1988)

  2. No Access

    Article

    Pharmacokinetics of intravenous captopril in healthy men

    The pharmacokinetic characteristics of intravenously-administered captopril were investigated in 7 healthy men 20 to 33 years old. Capropril, labeled with14C, was given by injection over a 1 min period at mean do...

    W. A. Creasey, R. A. Morrison, S. M. Singhvi in European Journal of Clinical Pharmacology (1988)

  3. No Access

    Chapter and Conference Paper

    The Clinical Pharmacology of SQ 31,000 (CS 514) in Healthy Subjects

    Atherosclerosis, with the attendant consequences of coronary heart disease and stroke, is the major cause of death in the United States and most developed countries. Elevated serum cholesterol and, in particul...

    H. Y. Pan, D. A. Willard, P. T. Funke, D. N. McKinstry in Drugs Affecting Lipid Metabolism (1987)